CME/CE Podcast: Primary Care’s Primary Role in the Effective Management of Pulmonary Arterial Hypertension
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
Effective Management of Pulmonary Arterial Hypertension: Primary Care’s Primary Role Podcast
Featuring Stacy A. Mandras, MD, FACC as faculty, moderated by Gregg Sherman, MD.
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening condition characterized by increased pulmonary vascular resistance which can lead to right heart failure and premature death. As first-line healthcare providers, primary care clinicians play a key role in the early recognition of PAH, and referral of patients to specialists to confirm the diagnosis. Thereafter, primary care providers (PCPs) also play a crucial role in the ongoing monitoring and management of PAH patients. However, in practice, early recognition and management of PAH is challenging as PAH does not become clinically manifest until pulmonary vascular disease is advanced. This activity will focus on PAH diagnostic tools, monitoring, and management strategies to optimize care and patient outcomes.
This podcast was recorded and is being used with the permission of the presenters.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Diagnose PAH using updated definitions and diagnostic tools
- Promote patient adherence through the management of adverse events that are associated with PAH therapies
This activity is accredited for CME/CE credit.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
Effective Management of Pulmonary Arterial Hypertension: Primary Care’s Primary Role Podcast
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).
This educational activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.